Etofenamate
CAS : 30544-47-9
Ref. 3D-FE23195
1g | 1.025,00 € | ||
50mg | 164,00 € | ||
100mg | 236,00 € | ||
250mg | 406,00 € | ||
500mg | 657,00 € |
Informations sur le produit
- 2-[[3-(Trifluoromethyl)phenyl]amino]benzoic acid 2-(2-hydroxyethoxy)ethyl ester2-(2-Hydroxyethoxy)ethyl fufenamateBayrogel
- 2-(2-Hydroxyethoxy)ethyl 2-{[3-(trifluoromethyl)phenyl]amino}benzoate
- 2-(2-Hydroxyethoxy)ethyl flufenamate
- 2-[[3-(Trifluoromethyl)phenyl]amino]benzoic Acid 2-(2-Hydroxyethoxy)ethyl Ester
- 30544-47-9
- Anthranilic acid, N-(α,α,α-trifluoro-m-tolyl)-, 2-(2-hydroxyethoxy)ethyl ester
- B 577
- Bay-d 1107
- Bayrogel
- Benzoic acid, 2-[[3-(trifluoromethyl)phenyl]amino]-, 2-(2-hydroxyethoxy)ethyl ester
- Voir d'autres synonymes
- Glasel
- N-(a,a,a-Trifluoro-m-tolyl)anthranilic Acid 2-(2-Hydroxyethoxy)ethyl Ester
- Reumon
- Rheumon
- Rheumon gel
- Traumon Gel
- Tv 485
- Whr 5020
Etofenamate is a non-steroidal anti-inflammatory drug (NSAID) that inhibits the production of prostaglandins, thereby reducing inflammation and pain. It has been shown to inhibit the release of inflammatory mediators, such as histamine, from mast cells and eosinophils in vivo, as well as decrease skin cancer and cell leukemia in vitro. Etofenamate also inhibits polymorphonuclear leucocytes and lymphocyte transformation. Etofenamate is a glycol ester with a carboxylic acid group at one end, which is metabolized into an alcohol form. These active metabolites are excreted in human serum after oral administration.
Propriétés chimiques
Question d’ordre technique sur : 3D-FE23195 Etofenamate
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages